Peg Horn | Chief Operating Officer |
Mark Goldsmith | Chairman & Chief Executive Officer |
Jack Anders | Senior Vice President of Finance & Principal Accounting Officer |
Steve Kelsey | President of R&D |
Michael Schmidt | Guggenheim |
Jonathan Chang | SVB Leerink |
Eric Joseph | JPMorgan |
Marc Frahm | Cowen & Company |
Chris Shibutani | Goldman Sachs |
Benjamin Burnett | Stifel |
Good day, ladies and gentlemen, and welcome to the Revolution Medicines Third Quarter Fiscal 2021 Financial Results Conference Call and Webcast. At this time, all participants are in listen-only mode.
Following management's prepared remarks, we will hold a Q&A session. [Operator Instructions]. Please be advised that today's conference call is being recorded.